Federal Circuit Rejects Bid For 'Greater Relief' Than Arthrex Remedy

Mealey's (September 10, 2020, 2:06 PM EDT) -- WASHINGTON, D.C. — Although agreeing with a patent owner that a final written decision by the Patent Trial and Appeal Board declaring various patent claims obvious or anticipated must be vacated and remanded pursuant to Arthrex, Inc. v. Smith & Nephew, Inc., No. 18-2140 (Fed. Cir.), the Federal Circuit U.S. Court of Appeals on Sept. 9 stopped short of awarding the patent owner's request for "greater relief" (Snyders Heart Valve LLC v. St. Jude Medical LLC, No. 19-2111, Fed. Cir., 2020 U.S. App. LEXIS 28521)....